Ribosomal protein L34 pseudogene 23 (RPL34P23)

Ribosomal protein L34 pseudogene 23 (RPL34P23) is a processed pseudogene that shares sequence similarity with the functional ribosomal protein L34 gene (RPL34), a component of the 60S ribosomal subunit involved in protein synthesis[2][7]. Pseudogenes like RPL34P23 do not produce functional protein products and are generally considered transcriptionally inactive; they do not have established roles as therapeutic targets or disease markers[2][6][7]. RPL34P23 is a pseudogene, not a protein-coding gene, and therefore does not function as a therapeutic target, receptor, enzyme, transporter, or other conventional drug target class[2][6][7]. The functional ribosomal protein L34 (RPL34) is part of the ribosome and participates in protein synthesis[1][3][5], but pseudogenes such as RPL34P23 lack coding potential and are generally excluded from pharmacological targeting. The "P" in gene nomenclature stands for "pseudogene," denoting a non-functional genomic sequence derived from a functional gene[2][6]. No disease associations, drug interactions, therapeutic mechanisms, biomarkers, or safety concerns are known or reported for RPL34P23; such roles, if described, would pertain to the functional RPL34 gene or protein and not this pseudogene[2][6][7]. The presence of RPL34 pseudogenes, including RPL34P23, is typical in the human genome; they are the result of gene duplication or retrotransposition events and are commonly catalogued but not actively functional[2][6].

Other names

RPL34_13_1184RPL34P23